Full-Time

Global Product Development Lead

Neuro-Oncology

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Postgraduate qualifications in science or life sciences (ideally PhD) required
  • 8+ years’ pharmaceutical/biotechnology industry experience including direct experience in drug development (ideally in oncology) required
  • 3+ years’ project and budget management experience
  • An understanding of the regulatory environment in the US, EU and APAC pertaining to drug development
  • Experience working as part of, and also managing, a cross-functional team
Responsibilities
  • Work as part of a cross-functional team to create/manage a Target Product Profile and Product Development plan for the targeted therapy in solid tumours.
  • Lead cross-functional teams to deliver the program development milestones up to the end of Phase 2 clinical evaluation within project timelines and budget.
  • Act as the primary point of contact for the program and ensure that excellent communication is maintained both internally and externally.
  • Oversight of a Project Manager to ensure application of project management best practice.
  • Complete oversight of the delivery of product development plans, more specifically:
  • Maintenance of up-to-date documentation of product positioning and target product profile.
  • Progress tracking of all activities against the development plan and notification of potential delays and/or other changes.
  • Documentation and tracking of the Program budget; working with Finance and the project manager to ensure contracts and costs are recorded in an accurate and timely manner.
  • Work with senior management to assess product development risks and compile risk mitigation and scenario plans.
  • Conduct regular reviews to ensure appropriate Program documentation is in place and to monitor project progress, scope, timelines and budget.
  • Ensuring all Program Team members and the Executive are kept informed of project status, costs and risks.
  • Supporting Project Managers in preparing periodic reports to internal stakeholders, including senior management, on the status and progress of the Program.
  • Contribute to the definition and delivery of Corporate Objectives.
  • Preparing timely and accurate reports for Management.
  • Maintaining current awareness of Program-related scientific, clinical and commercial functional knowledge.
  • Represent the program team at internal and external meetings.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products for diagnosing and treating cancer and rare diseases using targeted radiation. Their products aim to enhance treatment decisions and offer personalized therapy for conditions that lack effective solutions. The company focuses on areas such as prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix has a global supply chain to manufacture and distribute its specialized products to healthcare providers and patients. Unlike many competitors, Telix emphasizes sustainability, patient care, and ethical practices in its operations. The goal of Telix Pharmaceuticals is to improve the quality of life for patients by providing advanced diagnostic and therapeutic options.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

18%

1 year growth

43%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.

Help us improve and share your feedback! Did you find this helpful?